Blanver to invest BRL 592m to build third factory in Mairiporã (SP), to expand two other units in São Paulo
Blanver investirá BRL 592m para construir terceira fábrica em Mairiporã (SP) e ampliar outras duas unidades em São Paulo
Intel ID : 413094
|
||||
| Intel ID | 413094 | ||
| Value | EUR 96,36m | ||
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
||
|
Financial Data - Blanver
(31 Dec 2024) |
Revenue: EUR 129,69m EBITDA: EUR 12,14m Net Debt: EUR 16,14m Exchange Rate: 
|
||
| Date |
|
||
| Country | |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
10.01.99 Other Business & Professional Support Services (Primary) 10 Business Services / 10.01 Business & Professional Support Services |
||
| Secondary Subsectors (TTRSC) |
10.01.01 BPO/Outsource Services 10 Business Services / 10.01 Business & Professional Support Services 30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
10.01.99 Other Business & Professional Support Services 10 Business Services / 10.01 Business & Professional Support Services |
||
| Secondary Sectors (TTRSC) |
10.01.01 BPO/Outsource Services 10 Business Services / 10.01 Business & Professional Support Services 30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.